JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer
10.1186/bcr3200
Saved in:
Main Authors: | Lee, Y.F., Miller, L.D., Chan, X.B., Black, M.A., Pang, B., Ong, C.W., Salto-Tellez, M., Liu, E.T., Desai, K.V. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/117057 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer
by: Soon, W.W., et al.
Published: (2014) -
Overexpression of neurone glial-related cell adhesion molecule is an independent predictor of poor prognosis in advanced colorectal cancer
by: Chan, J.Y., et al.
Published: (2014) -
Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells
by: Loh, Y.-H., et al.
Published: (2014) -
Discovery and characterization of JMJD6 as a novel oncogene.
by: Lee, Yi Fang.
Published: (2012) -
Jmjd3 contributes to the control of gene expression in LPS-activated macrophages
by: De Santa, F., et al.
Published: (2013)